JFL Life Sciences Limited

₹12.35As of Sun 8 Nov 2026, 12:00 UTC
NSE:JFLLIFEHealthcare
Country India
PE (Fwd) •••
TSR 4Y CAGR (3.02%)
Div yield —
ROE 19.32%
Pharmaceutical Preparations
Beta (5Y) (0.24)
PE TTM 4.503
TSR TTM (6.25%)
Mkt cap ₹407.5M
ROIC 15.57%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹15
21.20%
(23.73%)
Hold 3|5|11|10|8
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.17
0.18
0.19
0.19
17.82%
19.96%
26.74%
18.91%
Revenue₹M
25.52
25.76
27.03
28.59
(7.83%)
(4.67%)
2.55%
10.68%
Peers (US$4.146M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.124
0.349
0.279
EBIT/Intx
1.158
0.349
0.430
Own earn%
(19.81)
(148.67)
(148.04)
Sh yield%
39.53
35.03
35.32
Owners
Insiders/Inst%
4.72
89.93
Short interest%
3.87
SBC / revenue%
3.47
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
9–13
$1 testx
—
Incr. ROIC%
3